{"@context":"https:\/\/schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Real-World Survival Among Patients with HER2-Positive and HER2-Low Metastatic Malignancies Who Received HER2-Targeting Agents","item":"https:\/\/www.regionalcancercare.org\/trials\/real-world-survival-among-patients-with-her2-positive-and-her2-low-metastatic-malignancies-who-received-her2-targeting-agents\/#breadcrumbitem"}]}